Skip to main content
    H

    Hinge Health, Inc. (HNGE)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $114.42
    -6.87 (-5.66%)

    Market Cap: $9.86B

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Hinge Health, Inc. (HNGE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Hinge Health (HNGE) has a market cap of $9.86B and an enterprise value of $9.65B. Revenue grew 49.86% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 2.15% below the market cap, as cash exceeds debt.

    Market Cap$9.86B
    Enterprise Value$9.65B
    Latest price (Nov 17, 2026)$114.42

    Key Dates

    Last Earnings DateNov 2, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.40% in the quarter ended Sep 30, 2026 and grew 1.81% a year over 2 years.

    Shares Outstanding80.87M
    Shares Change (YoY)+2.55%
    Shares Change (QoQ)+2.40%
    Share Count Growth (2Y CAGR)+1.81%

    Valuation Ratios

    Sales and book value multiples are 11.6x and 30.9x.

    P/E Ratio53.7x
    Forward P/E44.3x
    P/S Ratio11.6x
    Forward P/S11.2x
    P/B Ratio30.9x
    P/TBV Ratio78.4x
    P/FCF Ratio29.3x
    P/OCF Ratio30.5x
    PEG Ratio1.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 37.3x EBITDA and 28.7x free cash flow.

    EV / Earnings57.3x
    EV / Sales12.0x
    EV / EBITDA37.3x
    EV / FCF28.7x

    Price Statistics

    The stock is up 179.35% over 52 weeks and trades 9.11% above its 50-day average.

    Beta (1Y)1.14
    52-Week Change+179.35%
    1-Month Change+10.06%
    3-Month Change+29.35%
    6-Month Change+108.19%
    Total Return (1Y)+179.35%
    Return vs SPY (1Y)+170.12%
    Max Drawdown (1Y)-37.72%
    Sharpe Ratio (1Y)2.03
    Correlation with SPY (1Y)0.31
    50-Day Average$104.87
    200-Day Average$71.78
    52-Week Range$30.08 to $126.40
    RSI (14 Days)51.6
    Average Volume (20 Days)1.96M

    Financial Position

    Current assets cover 1.04x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.04x
    Quick Ratio1.01x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 56.21% and return on assets is 19.26% over the last 12 months.

    Return on Equity (ROE)56.21%
    Return on Assets (ROA)19.26%
    Asset Turnover0.97x
    Inventory Turnover6.36x
    Receivables Turnover5.85x
    Cash Conversion Cycle-106 days

    Scores

    HNGE has an Altman Z-Score of 9.76, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score9.76
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $800.82M over the last 12 months.

    Revenue$800.82M
    Revenue Growth (YoY)+49.86%
    Gross Profit$686.68M
    Operating Income$150.09M
    Pretax Income$166.31M
    Net Income$168.31M
    EBITDA$215.24M
    Reported EPS (TTM)$2.13

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Shareholder equity funds 34.26% of the $874.08M in total assets.

    Cash and Equivalents$211.55M
    Total Debt$0
    Net Cash$211.55M
    Net Cash Per Share$2.62
    Working Capital$23.15M
    Shareholder Equity$299.42M
    Book Value Per Share$3.70
    Tangible Book Value$118.06M
    Tangible Book Per Share$1.46
    Total Assets$874.08M
    Total Liabilities$574.66M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    After $7.69M of capital spending, operating cash flow left $315.30M of free cash flow.

    Operating Cash Flow$322.99M
    Capital Expenditures$7.69M
    Free Cash Flow$315.30M
    FCF Per Share$5.05
    Depreciation and Amortization$78.16M
    Share Repurchases$222.70M

    Trailing 12 months through Sep 30, 2026.

    Margins

    The operating margin is 18.74%.

    Gross Margin85.75%
    Operating Margin18.74%
    Pretax Margin20.77%
    Net Margin21.02%
    EBITDA Margin26.88%
    FCF Margin39.37%

    Growth

    Book Value Per Share Growth (2Y CAGR)-37.88%
    Tangible Book Per Share Growth (2Y CAGR)-46.66%

    Dividends and Yields

    HNGE does not pay a dividend. Its free cash flow yield is 3.41%.

    Earnings Yield1.86%
    FCF Yield3.41%
    Buyback Yield2.32%
    Shareholder Yield2.32%

    Peer Position

    Against 8 similar companies, HNGE has the 2nd highest P/E.

    P/E Ratio53.7x vs 34.1x median
    P/S Ratio11.6x vs 4.6x median
    Revenue Growth (Trailing 4 Quarters, YoY)+49.86% vs +14.93% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HNGE

    What is HNGE's market cap?

    Hinge Health has a market cap of $9.86B. Its enterprise value, which adds debt and subtracts cash, is $9.65B.

    What is HNGE's P/E ratio?

    Hinge Health has a trailing P/E ratio of 53.7x and a forward P/E of 44.3x.

    How many shares of HNGE are outstanding?

    Hinge Health has 80.87M shares outstanding. The count is up 2.55% from a year earlier.

    Does HNGE pay a dividend?

    No. Hinge Health does not pay a dividend.

    How much debt does HNGE have?

    Hinge Health has $0 of total debt and $211.55M of cash and equivalents, a net cash position of $211.55M.